855 related articles for article (PubMed ID: 25403813)
1. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
[TBL] [Abstract][Full Text] [Related]
2. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Rose N; Heidenreich T; Jelinek L; Alsleben H; Wahl K; Philipsen A; Voderholzer U; Maier JG; Moritz S
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):223-233. PubMed ID: 30446822
[TBL] [Abstract][Full Text] [Related]
3. Mindfulness-based cognitive therapy as an augmentation treatment for obsessive-compulsive disorder.
Key BL; Rowa K; Bieling P; McCabe R; Pawluk EJ
Clin Psychol Psychother; 2017 Sep; 24(5):1109-1120. PubMed ID: 28194835
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of mindfulness-based cognitive therapy in patients with obsessive-compulsive disorder and residual symptoms after cognitive behavioral therapy: Twelve-month follow-up of a randomized controlled trial.
Cludius B; Landmann S; Rose N; Heidenreich T; Hottenrott B; Schröder J; Jelinek L; Voderholzer U; Külz AK; Moritz S
Psychiatry Res; 2020 Sep; 291():113119. PubMed ID: 32534361
[TBL] [Abstract][Full Text] [Related]
5. Pallidum volume as a predictor for the effectiveness of mindfulness-based cognitive therapy and psycho-education in unmedicated patients with obsessive-compulsive disorder.
Zhang C; Zhang X; Li W; Zhang T; Zhang Z; Lu L; Didonna F; Fan Q
Compr Psychiatry; 2024 May; 131():152462. PubMed ID: 38354586
[TBL] [Abstract][Full Text] [Related]
6. Participant perspectives on the acceptability and effectiveness of mindfulness-based cognitive behaviour therapy approaches for obsessive compulsive disorder.
Leeuwerik T; Cavanagh K; Forrester E; Hoadley C; Jones AM; Lea L; Rosten C; Strauss C
PLoS One; 2020; 15(10):e0238845. PubMed ID: 33085672
[TBL] [Abstract][Full Text] [Related]
7. Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial.
Kyrios M; Ahern C; Fassnacht DB; Nedeljkovic M; Moulding R; Meyer D
J Med Internet Res; 2018 Aug; 20(8):e242. PubMed ID: 30089607
[TBL] [Abstract][Full Text] [Related]
8. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
9. ØCD: protocol for the development and evaluation of a cognitive-behavioral prevention program for obsessive-compulsive disorder.
Cardoș RAI; Dumitru EP; David OA
BMC Psychiatry; 2024 May; 24(1):348. PubMed ID: 38724961
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).
Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
Health Technol Assess; 2017 Jun; 21(37):1-132. PubMed ID: 28681717
[TBL] [Abstract][Full Text] [Related]
11. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
[TBL] [Abstract][Full Text] [Related]
12. Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.
Lovell K; Bower P; Gellatly J; Byford S; Bee P; McMillan D; Arundel C; Gilbody S; Gega L; Hardy G; Reynolds S; Barkham M; Mottram P; Lidbetter N; Pedley R; Molle J; Peckham E; Knopp-Hoffer J; Price O; Connell J; Heslin M; Foley C; Plummer F; Roberts C
PLoS Med; 2017 Jun; 14(6):e1002337. PubMed ID: 28654682
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder.
Mathur S; Sharma MP; Balachander S; Kandavel T; Reddy YJ
J Affect Disord; 2021 Mar; 282():58-68. PubMed ID: 33401124
[TBL] [Abstract][Full Text] [Related]
14. Remission and Relapse Across Three Years in Pediatric Obsessive-Compulsive Disorder Following Evidence-Based Treatments.
Ivarsson T; Jensen S; Højgaard DRMA; Hybel KA; Torp NC; Melin K; Nissen JB; Weidle B; Thomsen PH; Dahl K; Skarphedinsson G
J Am Acad Child Adolesc Psychiatry; 2024 May; 63(5):519-527. PubMed ID: 38070870
[TBL] [Abstract][Full Text] [Related]
15. Personalized exposure and experience sampling method feedback versus exposure as usual for obsessive-compulsive disorder: a study protocol for a randomized controlled trial.
Hoogerwerf E; Greeven A; Goekoop R; Spinhoven P
Trials; 2024 Jan; 25(1):43. PubMed ID: 38217045
[TBL] [Abstract][Full Text] [Related]
16. Study protocol for a single-blind, randomised controlled, non-inferiority trial of internet-based versus face-to-face cognitive behaviour therapy for obsessive-compulsive disorder.
Rück C; Lundström L; Flygare O; Enander J; Bottai M; Mataix-Cols D; Andersson E
BMJ Open; 2018 Sep; 8(9):e022254. PubMed ID: 30185575
[TBL] [Abstract][Full Text] [Related]
17. Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents: protocol for a randomised clinical trial (the TECTO trial).
Pagsberg AK; Uhre C; Uhre V; Pretzmann L; Christensen SH; Thoustrup C; Clemmesen I; Gudmandsen AA; Korsbjerg NLJ; Mora-Jensen AC; Ritter M; Thorsen ED; Halberg KSV; Bugge B; Staal N; Ingstrup HK; Moltke BB; Kloster AM; Zoega PJ; Mikkelsen MS; Harboe GS; Larsen KF; Clemmensen LKH; Lindschou J; Jakobsen JC; Engstrøm J; Gluud C; Siebner HR; Thomsen PH; Hybel K; Verhulst F; Jeppesen P; Jepsen JRM; Vangkilde S; Olsen MH; Hagstrøm J; Lønfeldt NN; Plessen KJ
BMC Psychiatry; 2022 Mar; 22(1):204. PubMed ID: 35305587
[TBL] [Abstract][Full Text] [Related]
18. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
[TBL] [Abstract][Full Text] [Related]
19. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
[TBL] [Abstract][Full Text] [Related]
20. Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.
Simpson HB; Gorfinkle KS; Liebowitz MR
J Clin Psychiatry; 1999 Sep; 60(9):584-90. PubMed ID: 10520976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
